Publish Ahead of Print

Original Article

Evaluation of acute skin toxicity during radiotherapy for breast cancer in elderly patients
Daniel Sampaio Vieira, Marcio Lemberg Reisner, Juliana Depra Panichella, Isabella Peixoto Barbosa
Adjuvant whole breast radiotherapy with simultaneous integrated boost to tumor bed with intensity modulated radiotherapy technique in elderly breast cancer patients
Kuan-Wen Chen, Hsiu-Ting Hsu, Jia-Fu Lin, Hui-Ling Yeh, Dah-Cherng Yeh, Chin-Yao Lin, Siwa Chan, He-Yuan Hsieh
Circ-ITCH correlates with less advanced tumor features as well as prolonged survival, and it inhibits cells proliferation but promotes apoptosis in non-small cell lung cancer
Zhenhua Li, Xiaoqun Guo, Shan Gao
Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma
Xue Han, Yangkui Gu, Shaolong Li, Minshan Chen, Qingqing Cai, Jinhua Huang
Efficacy analysis of endoscopic submucosal dissection in gastric adenocarcinoma of fundic gland type: five cases of more than 36 months of follow-up
Yang Li, Youzhu Lu, Chao Yu, Jun Xiao, Shutang Han
Serum oxidative stress is an independent prognostic marker in colorectal cancer
Kiichi Sugimoto, Kazuhiro Sakamoto, Masaya Kawai, Shingo Kawano, Shinya Munakata, Shun Ishiyama, Makoto Takahashi, Yutaka Kojima, Yuichi Tomiki
Impact of the time from the completion of neoadjuvant chemotherapy to surgery on the outcomes of patients with gastric cancer
Chaorui Wu, Hong Zhou, Tongbo Wang, Xiaojie Zhang, Yingtai Chen, Dongbing Zhao
Effect of artesunate on apoptosis and autophagy in tamoxifen resistant breast cancer cells (TAM-R)
Xiaoqing Ding, Wei Yue, Haiyan Chen

Review Article

Pathological and molecular characteristics of inflammatory breast cancer
Maurizio Di Bonito, Monica Cantile, Gerardo Botti
Surgery on primary melanoma of the breast
Qi Huang, Xiao-Hua Zhang, Ling-Ji Guo, Yu-Jun He
Current state of surgical management for male breast cancer
Vladimir Popa-Nimigean, Muneer Ahmed
Toward precision medicine in inflammatory breast cancer
Giulia Viale, Antonio Marra, Giuseppe Curigliano, Carmen Criscitiello
Rare epithelial breast cancer: surgery and adjuvant therapy
Aida Abdelwahed, Muneer Ahmed
Breast radiotherapy in elderly women: myths, controversies, and current techniques in the adjuvant setting
Ana Aurora Díaz Gavela, Blanca Vaquero Barron, Elia del Cerro Peñalver, Felipe Couñago
Treatment and patient related quality of life issues in elderly and very elderly breast cancer patients
Bengü Depboylu
Examining the evolving utility of 18FDG-PET/CT in breast cancer recurrence
Navid Djassemi, Shilpa Rampey, Juhi Motiani
Stereotactic radiation therapy for breast cancer in the elderly
Pauline Jardel, Emmanuel Kammerer, Hugo Villeneuve, Juliette Thariat
Partial breast irradiation: when less could be more
Alexandre Vasconcellos Alvim Ambrósio, Guilherme Rocha Melo Gondim, Murilo José Inocente Inácio, Antônio Cássio de Assis Pellizzon
Can elderly patients with low-risk breast cancer benefit from radiotherapy?
Claudio Fuentes-Sánchez, María Elena García-Morales, Carmen González-San Segundo
The role of radiation therapy and systemic therapies in elderly with breast cancer
Valerio Nardone, Sara Falivene, Francesca Maria Giugliano, Marcella Gaetano, Pasqualina Giordano, Matteo Muto, Bruno Daniele, Cesare Guida
Accelerated partial breast irradiation in elderly breast cancer patients
Igor Sirák, Miroslav Hodek, Pavel Jandík, Jakub Grepl, Petr Paluska, Jiří Petera
Controversies of radiation therapy omission in elderly women with early stage invasive breast cancer
Ibrahim Abu-Gheida, Lubna Hammoudeh, Hikmat Abdel-Razeq
Post-mastectomy and post-breast conservation surgery pain syndrome: a review of etiologies, risk prediction, and trends in management
Victor E. Chen, Benjamin A. Greenberger, Zheng Shi, Shefali Gajjar, Wenyin Shi, Waleed F. Mourad, Weisi Yan
Morphological and pathological features of basal-like breast cancer
Gerardo Botti, Monica Cantile, Francesca Collina, Margherita Cerrone, Sabrina Sarno, Annamaria Anniciello, Maurizio Di Bonito
Surgery on breast cancer in pregnancy
Viola Liberale, Elisa Tripodi, Laura Ottino, Nicoletta Biglia
Radiation therapy for the elderly—change of concepts in breast cancer?
András Szigeti, Edit Szigeti, Aneta Grajda
Angiosarcoma of the breast, the unknown—a review of the current literature
Emanuela Esposito, Franca Avino, Raimondo di Giacomo, Ivana Donzelli, Ugo Marone, Maria Teresa Melucci, Chiara Rinaldo, Fulvio Ruffolo, Ruggero Saponara, Claudio Siani, Raffaele Tortoriello, Gerardo Botti, Massimo Rinaldo, Alfredo Fucito
Extreme weekly hypofractionation in breast cancer in elderly
Sonia Blanco Parajón, María Paz Pérez Payo, Aranzazu Iglesias Agüera, Maria Jesús Caminero Cuevas, Mercedes Canteli Castañón, Diana Alonso Sánchez, Germán José Juan Rijo
Get Permission
Post mastectomy radiotherapy for elderly patients with intermediate risk (T1-2N1 OR T3N0) breast cancer: a systematic review and meta-analysis
Michelle Tseng, Balamurugan Vellayappan, Rachel Choong, Gokula Kumar Appalanaido, Yu Yang Soon
Quality of life for elderly breast cancer patients: a new regard
Mohamed Abdelrahim Mahfouz, Mohammed Yahia Almaghrabi
The management of elderly patients with brain metastases from breast cancer
Henry Ruiz-Garcia, Lina Marenco-Hillembrand, Jennifer L. Peterson, Katherine Tzou, Timothy D. Malouff, Kaisorn L. Chaichana, Daniel M. Trifiletti, Laura Vallow
Rare sites of breast cancer metastasis: a review
Rosa Di Micco, Letizia Santurro, Maria Luisa Gasparri, Veronica Zuber, Enrico Fiacco, Guglielmo Gazzetta, Chanel Elisha Smart, Alice Valentini, Oreste Davide Gentilini
The role of proton beam therapy in the management of elderly breast cancer patients
Benjamin J. Rich, David Asher, Bosco Giap, Huan Giap
Palliative care access in the elderly metastatic breast cancer population: obstacles and opportunities
Taylor MacDonald, Vignesh Krishnan, William Alexander Wilson
The functions of long non-coding RNAs in colorectal cancer
Huaiming Wang, Chengzhi Huang, Xueqing Yao

Case report

Magnetic susceptibility artefact on MRI mimicking lymphadenopathy: description of a nasopharyngeal carcinoma patient
Feng Zhao, Xiaokai Yu, Jiayan Shen, Xinke Li, Guorong Yao, Xiaoli Sun, Fang Wang, Hua Zhou, Zhongjie Lu, Senxiang Yan

Brief Report

Rare GCC2-ALK fusion G13:A20 detected by next generation sequencing in non-small cell lung cancer patients and treatment response
Jing Qin, Daxiong Zeng, Fajun Xie, Ruoying Yu, Xue Wu, Kaihua Liu, Yang W. Shao, Hongyang Lu, Junhong Jiang

Letter to the Editor

Androgen deprivation therapy in high risk prostate cancer
Ritchell Van Dams, Amar U. Kishan

Editorial Commentary

Pembrolizumab monotherapy in advanced NSCLC patients with low PD-L1 expression: is there real evidence?
Alfonso Fiorelli, Fabiana Vitiello, Floriana Morgillo, Mario Santagata, Chiara Spuntarelli, Marina Di Domenico, Mario Santini, Andrea Bianco
Sentinel node mapping in endometrial cancer
Giorgio Bogani, Antonino Ditto, Valentina Chiappa, Francesco Raspagliesi
Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
Vito Lorusso, Simona Vallarelli, Francesco Giotta
Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?
Cem Onal
Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
Dana Mitchell, Mahua Dey
Importance of measurement repeatability of semi-quantitative imaging through PET-CT and PET-MR imaging in oncology
Adriano Massimiliano Priola, Sandro Massimo Priola
Revisiting anti-angiogenic therapy for recurrent glioblastoma
Katherine B. Peters
Local therapy in patients with metastatic prostate cancer: a new standard of care?
Benjamin Harper, Zachary Klaassen, Christopher J. D. Wallis
First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer
Camille Travert, Pascale Tomasini, Arnaud Jeanson, Laurent Greillier, Fabrice Barlesi
Targeting the reversible drug-tolerant state: aurora kinase A, is that the final answer?
Kenichi Suda
Anti-angiogenesis boosts chemo-immunotherapy in patients with EGFR mutations or baseline liver metastases: insights from IMpower150 study
Sara Elena Rebuzzi, Francesco Facchinetti, Marcello Tiseo
A mechanism for the tissue specificity in BAP1 cancer syndrome
Yuichi J. Machida
Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma
Yue Zhang, Shenhong Wu
Long-term efficacy of immune checkpoint inhibitors in advanced NSCLC: challenges and opportunities—a commentary of the 3-year follow-up of the KEYNOTE-001 trial
Alessandro Russo, Katherine A. Scilla, Christian Rolfo
The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
Nityam Rathi, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami
High predictability for identifying Lynch syndrome via microsatellite instability testing or immunohistochemistry in all Lynch-associated tumor types
John M. Carethers
Immune checkpoint inhibitors and the shared epitope theory: from hypothesis to practice
Shalom Lerrer, Adam Mor
Stepping in the right direction but still some ways to go
Alfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender
Lomustine and temozolomide for newly diagnosed glioblastoma with methylated MGMT promoter: Lessons from the CeTeG/NOA- 09 trial
Ivo W. Tremont-Lukats, Bin S. Teh
Which is better, EGFR-TKI mono or combination for non-small cell lung cancer with mutated EGFR?
Shigeru Tanzawa, Masashi Ishihara, Terunobu Haruyama, Ryosuke Ochiai, Takahiko Sakamoto, Takeshi Honda, Shuji Ota, Yasuko Ichikawa, Kiyotaka Watanabe, Nobuhiko Seki
Robotic surgery in early-stage endometrial cancer
Giacomo Corrado, Simone Bruni, Enrico Vizza
Discernable differences in the genetic and molecular profile of cerebellar glioblastoma
Muhibullah S. Tora, D. Cory Adamson
Androgen receptor splice variant 7 in castration resistant prostate cancer treated with hormonal therapy: what is in the pipeline?
Martina Chirra, Roberto Petrioli, Giandomenico Roviello
New approaches to model glioblastoma in vitro using brain organoids: implications for precision oncology
Guillermo A. Gomez, Mariana Oksdath, Michael P. Brown, Lisa M. Ebert
Neoadjuvant therapy in localized non-small cell lung cancer: can we do better than chemotherapy?
Brittney Chau, Ashwin Shinde, Arya Amini